Global Sickle Cell Disease Therapeutics Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Sickle Cell Disease Therapeutics

• 1.1 Definition of Sickle Cell Disease Therapeutics
• 1.2 Sickle Cell Disease Therapeutics Segment by Type
  • 1.2.1 Global Sickle Cell Disease Therapeutics Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 Sickle Cell Anemia
  • 1.2.3 Sickle Beta Thalassemia
  • 1.2.4 Sickle Hemoglobin C Disease
• 1.3 Sickle Cell Disease Therapeutics Segment by Applications
  • 1.3.1 Global Sickle Cell Disease Therapeutics Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Hospitals
  • 1.3.3 Clinics
  • 1.3.4 Others
• 1.4 Global Sickle Cell Disease Therapeutics Overall Market
  • 1.4.1 Global Sickle Cell Disease Therapeutics Revenue (2014-2025)
  • 1.4.2 Global Sickle Cell Disease Therapeutics Production (2014-2025)
  • 1.4.3 North America Sickle Cell Disease Therapeutics Status and Prospect (2014-2025)
  • 1.4.4 Europe Sickle Cell Disease Therapeutics Status and Prospect (2014-2025)
  • 1.4.5 China Sickle Cell Disease Therapeutics Status and Prospect (2014-2025)
  • 1.4.6 Japan Sickle Cell Disease Therapeutics Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Sickle Cell Disease Therapeutics Status and Prospect (2014-2025)
  • 1.4.8 India Sickle Cell Disease Therapeutics Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Sickle Cell Disease Therapeutics
• 2.3 Manufacturing Process Analysis of Sickle Cell Disease Therapeutics
• 2.4 Industry Chain Structure of Sickle Cell Disease Therapeutics

3 Development and Manufacturing Plants Analysis of Sickle Cell Disease Therapeutics

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Sickle Cell Disease Therapeutics Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Sickle Cell Disease Therapeutics
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Sickle Cell Disease Therapeutics Production and Capacity Analysis
• 4.2 Sickle Cell Disease Therapeutics Revenue Analysis
• 4.3 Sickle Cell Disease Therapeutics Price Analysis
• 4.4 Market Concentration Degree

5 Sickle Cell Disease Therapeutics Regional Market Analysis

• 5.1 Sickle Cell Disease Therapeutics Production by Regions
  • 5.1.1 Global Sickle Cell Disease Therapeutics Production by Regions
  • 5.1.2 Global Sickle Cell Disease Therapeutics Revenue by Regions
• 5.2 Sickle Cell Disease Therapeutics Consumption by Regions
• 5.3 North America Sickle Cell Disease Therapeutics Market Analysis
  • 5.3.1 North America Sickle Cell Disease Therapeutics Production
  • 5.3.2 North America Sickle Cell Disease Therapeutics Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Sickle Cell Disease Therapeutics Import and Export
• 5.4 Europe Sickle Cell Disease Therapeutics Market Analysis
  • 5.4.1 Europe Sickle Cell Disease Therapeutics Production
  • 5.4.2 Europe Sickle Cell Disease Therapeutics Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Sickle Cell Disease Therapeutics Import and Export
• 5.5 China Sickle Cell Disease Therapeutics Market Analysis
  • 5.5.1 China Sickle Cell Disease Therapeutics Production
  • 5.5.2 China Sickle Cell Disease Therapeutics Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Sickle Cell Disease Therapeutics Import and Export
• 5.6 Japan Sickle Cell Disease Therapeutics Market Analysis
  • 5.6.1 Japan Sickle Cell Disease Therapeutics Production
  • 5.6.2 Japan Sickle Cell Disease Therapeutics Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Sickle Cell Disease Therapeutics Import and Export
• 5.7 Southeast Asia Sickle Cell Disease Therapeutics Market Analysis
  • 5.7.1 Southeast Asia Sickle Cell Disease Therapeutics Production
  • 5.7.2 Southeast Asia Sickle Cell Disease Therapeutics Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Sickle Cell Disease Therapeutics Import and Export
• 5.8 India Sickle Cell Disease Therapeutics Market Analysis
  • 5.8.1 India Sickle Cell Disease Therapeutics Production
  • 5.8.2 India Sickle Cell Disease Therapeutics Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Sickle Cell Disease Therapeutics Import and Export

6 Sickle Cell Disease Therapeutics Segment Market Analysis (by Type)

• 6.1 Global Sickle Cell Disease Therapeutics Production by Type
• 6.2 Global Sickle Cell Disease Therapeutics Revenue by Type
• 6.3 Sickle Cell Disease Therapeutics Price by Type

7 Sickle Cell Disease Therapeutics Segment Market Analysis (by Application)

• 7.1 Global Sickle Cell Disease Therapeutics Consumption by Application
• 7.2 Global Sickle Cell Disease Therapeutics Consumption Market Share by Application (2014-2019)

8 Sickle Cell Disease Therapeutics Major Manufacturers Analysis

• 8.1 AstraZeneca
  • 8.1.1 AstraZeneca Sickle Cell Disease Therapeutics Production Sites and Area Served
  • 8.1.2 AstraZeneca Product Introduction, Application and Specification
  • 8.1.3 AstraZeneca Sickle Cell Disease Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Eli Lilly
  • 8.2.1 Eli Lilly Sickle Cell Disease Therapeutics Production Sites and Area Served
  • 8.2.2 Eli Lilly Product Introduction, Application and Specification
  • 8.2.3 Eli Lilly Sickle Cell Disease Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Novartis
  • 8.3.1 Novartis Sickle Cell Disease Therapeutics Production Sites and Area Served
  • 8.3.2 Novartis Product Introduction, Application and Specification
  • 8.3.3 Novartis Sickle Cell Disease Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Pfizer
  • 8.4.1 Pfizer Sickle Cell Disease Therapeutics Production Sites and Area Served
  • 8.4.2 Pfizer Product Introduction, Application and Specification
  • 8.4.3 Pfizer Sickle Cell Disease Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Baxter
  • 8.5.1 Baxter Sickle Cell Disease Therapeutics Production Sites and Area Served
  • 8.5.2 Baxter Product Introduction, Application and Specification
  • 8.5.3 Baxter Sickle Cell Disease Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Emmaus Life Sciences
  • 8.6.1 Emmaus Life Sciences Sickle Cell Disease Therapeutics Production Sites and Area Served
  • 8.6.2 Emmaus Life Sciences Product Introduction, Application and Specification
  • 8.6.3 Emmaus Life Sciences Sickle Cell Disease Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Bluebird bio
  • 8.7.1 Bluebird bio Sickle Cell Disease Therapeutics Production Sites and Area Served
  • 8.7.2 Bluebird bio Product Introduction, Application and Specification
  • 8.7.3 Bluebird bio Sickle Cell Disease Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Blood Therapeutics
  • 8.8.1 Blood Therapeutics Sickle Cell Disease Therapeutics Production Sites and Area Served
  • 8.8.2 Blood Therapeutics Product Introduction, Application and Specification
  • 8.8.3 Blood Therapeutics Sickle Cell Disease Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 Sangamo Therapeutics
  • 8.9.1 Sangamo Therapeutics Sickle Cell Disease Therapeutics Production Sites and Area Served
  • 8.9.2 Sangamo Therapeutics Product Introduction, Application and Specification
  • 8.9.3 Sangamo Therapeutics Sickle Cell Disease Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 Acceleron Pharma
  • 8.10.1 Acceleron Pharma Sickle Cell Disease Therapeutics Production Sites and Area Served
  • 8.10.2 Acceleron Pharma Product Introduction, Application and Specification
  • 8.10.3 Acceleron Pharma Sickle Cell Disease Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 Arena Pharmaceuticals
• 8.12 Alnylam Pharmaceuticals

9 Development Trend of Analysis of Sickle Cell Disease Therapeutics Market

• 9.1 Global Sickle Cell Disease Therapeutics Market Trend Analysis
  • 9.1.1 Global Sickle Cell Disease Therapeutics Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Sickle Cell Disease Therapeutics Regional Market Trend
  • 9.2.1 North America Sickle Cell Disease Therapeutics Forecast 2019-2025
  • 9.2.2 Europe Sickle Cell Disease Therapeutics Forecast 2019-2025
  • 9.2.3 China Sickle Cell Disease Therapeutics Forecast 2019-2025
  • 9.2.4 Japan Sickle Cell Disease Therapeutics Forecast 2019-2025
  • 9.2.5 Southeast Asia Sickle Cell Disease Therapeutics Forecast 2019-2025
  • 9.2.6 India Sickle Cell Disease Therapeutics Forecast 2019-2025
• 9.3 Sickle Cell Disease Therapeutics Market Trend (Product Type)
• 9.4 Sickle Cell Disease Therapeutics Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Sickle Cell Disease Therapeutics Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List